Nimblemind, an AI company built to help healthcare institutions and researchers unlock the full value of their data, announced the launch of NimbleLabs. This latest product is a lightweight AI platform designed to make clinical data enrichment accessible to data science teams, researchers and students. With an intuitive upload-and-enrich workflow, NimbleLabs allows users to convert raw clinical data into structured, analysis-ready outputs – enabling insights in hours instead of months.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 2 September 2025
NimbleLabs uses AI to enrich multimodal data in preparation for analysis and modeling. The platform is purpose-built for healthcare institutions and innovators looking to accelerate research, improve data workflows, and experiment with AI-ready datasets without needing to build infrastructure from scratch. NimbleLabs supports commonly used data types in healthcare, such as: unstructured clinical notes, images, videos, streaming wearable data, patient surveys, and more.
Health Technology Insights: FDA Reviews Shionogi’s COVID-19 Prevention Pill NDA as the First Oral Therapy
“Healthcare needs AI that is clinically relevant, scalable, and trustworthy. NimbleLabs transforms raw clinical data into AI-ready datasets in hours, not months, empowering researchers and healthcare systems to accelerate discovery and build solutions in areas of medicine that have long been overlooked. This is how we bring AI from the lab to the bedside.”
- Brian Khan, MD, MBA, Medical Director of Digital Health and Well-Being, Internal Medicine Physician, UChicago Medicine AdventHealth
The platform builds on Nimblemind’s mission to help providers and researchers enrich multimodal clinical data with structure, traceability, and context. NimbleLabs harnesses a proprietary AI enrichment engine that provides automated preprocessing, intent detection, and specialty-specific enrichment tuned to real-world healthcare needs.
“We built NimbleLabs to unlock the full potential of healthcare data. By making it faster and easier to prepare datasets for AI, we’re helping providers and researchers spend less time on manual prep and more time delivering new discoveries, better care, and measurable impact.”
- Pi Zonooz, CEO and Co-founder of Nimblemind.ai
The launch follows Nimblemind.ai’s $2.5M seed round earlier this year, led by Bread & Butter Ventures with participation from Great Oaks VC, SpringTime Ventures, Techstars, and others. Nimblemind’s products are used by healthcare organizations across the US and Asia in several specialties, including: palliative care, gastroenterology, pathology, geriatrics, and public health.
Health Technology Insights: Predicine Submits PMA for Bladder Cancer Companion Diagnostic Assay
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
